NWI Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
NWI Management's LLY Position: Q1 2026 in Review
NWI Management increased its Eli Lilly (LLY) stake by 3,600% in Q1 2026, buying an estimated $54.7M and bringing the position to 55,500 shares worth $51M. The position accounts for 2.9% of the portfolio, ranked #11.
NWI Management first reported a position in LLY in Q1 2023 and has held it in 10 quarters since. The position peaked at $52.5M in Q4 2023. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- NWI Management held 55,500 shares of Eli Lilly worth $51M as of Q1 2026.
- NWI Management bought 54,000 Eli Lilly shares in Q1 2026, an estimated $54.7M.
- Eli Lilly made up 2.9% of NWI Management's portfolio in Q1 2026, its #11 holding.
- NWI Management first reported a position in Eli Lilly in Q1 2023 and has held it in 10 quarters since.
- NWI Management's Eli Lilly position peaked at $52.5M in Q4 2023.
- 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on NWI Management's 13F filing for Q1 2026, filed 15 May 2026.